Ocugen, Inc. - Common Stock (NQ:OCGN)

0.7084 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

37 38 Next >

3 Market ETF Stocks to Buy This Week on Fed Jitters ↗

March 14, 2022

The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.

Via InvestorPlace

Ocugen Is Two Strikes in With a Third in the Books ↗

March 08, 2022

Ocugen failed to get energency use authorization for pediatric use of Covaxin. OCGN stock has tanked as a result.

Via InvestorPlace

68 Biggest Movers From Friday ↗

March 07, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday. Mexco Energy Corporation (NYSE: MXC...

Via Benzinga

Why Is Ocugen (OCGN) Stock Down Today? ↗

March 04, 2022

Shares of OCGN stock are in the red after the company's Covaxin Covid-19 vaccine was declined EUA by the FDA. Here's what you should know.

Via InvestorPlace

Why Ocugen Shares Are Falling ↗

March 04, 2022

Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8%...

Via Benzinga

Is Sweetgreen Stock a Buy After Earnings? 3 Analysts Weigh In on SG. ↗

March 04, 2022

Sweetgreen (SG) stock is rising as we check it with analysts following the fast-casual restaurants' most recent earnings report.

Via InvestorPlace

43 Stocks Moving In Friday's Mid-Day Session ↗

March 04, 2022

Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after...

Via Benzinga

Is BABA Stock a Buy? 3 Analysts Weigh In on Alibaba. ↗

March 04, 2022

Alibaba (BABA) stock is in the news lately with the company's shares slipping and we're seeing what experts have to say.

Via InvestorPlace

Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection ↗

March 04, 2022

Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin.

Via InvestorPlace

Recap: Ocugen Q4 Earnings ↗

February 25, 2022

Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Also check...

Via Benzinga

Why Ocugen Shares Are Falling ↗

February 23, 2022

Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 19.6%...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; U.S. Economy Adds 678,000 Jobs ↗

March 04, 2022

U.S. stocks opened on a downbeat note this morning following the release of weekly jobless claims data. Following the market opening Friday, the Dow traded down 1.29% to 33,360.18...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 04, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo...

Via Benzinga

FDA Denies Pediatric EUA To Ocugen For Bharat Biotech's COVID-19 Vaccine Covaxin ↗

March 04, 2022

The FDA has declined to issue an Emergency Use Authorization (EUA) for Covaxin for active immunization to prevent COVID-19 in individuals 2 to 18 years of age. Ocugen...

Via Benzinga

The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan ↗

March 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In...

Via Benzinga

Looking Into Ocugen Inc's Recent Short Interest ↗

March 02, 2022

Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 8.35% since its last report. The company recently reported that it has 54.94 million shares sold short, which is 30.23...

Via Benzinga

Earnings Scheduled For February 25, 2022 ↗

February 25, 2022

Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...

Via Benzinga

63 Biggest Movers From Yesterday ↗

February 24, 2022

Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a...

Via Benzinga

Is OCGN Stock a Buy After 20% Plunge? One Analyst Thinks It Can Go to $15. ↗

February 23, 2022

Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock?

Via InvestorPlace

February 23, 2022

These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold.

Via InvestorPlace

40 Stocks Moving In Wednesday's Mid-Day Session ↗

February 23, 2022

Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share...

Via Benzinga

Vertiv News: Why Is VRT Stock Plunging Today? ↗

February 23, 2022

Vertiv (VRT) stock isn't doing so hot on Wednesday following the release of the manufacturing company's earnings report for Q4 2021.

Via InvestorPlace

OCGN Stock Alert: The $50 Million Reason Ocugen Is Tanking Today ↗

February 23, 2022

After rising sharply in recent days, Ocugen shares are again falling on news that the company is issuing $50 million of common stock.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 23, 2022

Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 23, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...

Via Benzinga

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 22, 2022

Gainers Revelation Biosciences (NASDAQ:REVB

Via Benzinga

Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval ↗

February 22, 2022

Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point.

Via InvestorPlace

Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher ↗

February 22, 2022

U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.